Medicare Enrolled
Dr. Erik Pasin, MD
Urology Physician · Mission Viejo, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Pasin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Pasin?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Pasin
Dr. Erik Pasin is an urology physician in Mission Viejo, CA, with 17 years of NPI registration. Based on federal Medicare data, Dr. Pasin performed 10,841 Medicare services across 5,132 unique beneficiaries.
Between the years covered by Open Payments, Dr. Pasin received a total of $6,767 from 63 pharmaceutical and/or device companies across 316 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Pasin is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years in practice
▲ Top 11% volume in CA
$6,767 industry payments
Medicare Practice Summary
Medicare Utilization ↗10,841
Medicare services
Top 11% in CA for urology physician
5,132
Unique beneficiaries
$45
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~638 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| BCG treatment for bladder cancer | 3,367 | $2 | $5 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
2,265 | $72 | $160 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
1,309 | $3 | $10 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
1,218 | $9 | $60 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
339 | $102 | $240 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
282 | $132 | $360 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 262 | $134 | $600 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
223 | $218 | $460 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
198 | $12 | $60 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
180 | $0 | $1 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
171 | $20 | $45 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
119 | $90 | $260 |
| Limited ultrasound of pelvis A focused ultrasound exam of the pelvic area to evaluate specific structures. This procedure provides images of the pelvis to assist in medical assessment. |
110 | $39 | $150 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
90 | $50 | $160 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
87 | $148 | $440 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
69 | $77 | $230 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
63 | $102 | $230 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
61 | $129 | $400 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
59 | $53 | $300 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
46 | $211 | $480 |
| Implantable tissue marker, each A small marker is implanted into tissue to serve as a reference point for future medical imaging or procedures. |
39 | $57 | $170 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
36 | $21 | $315 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
31 | $6 | $40 |
| Complex urodynamic pressure measurement A test that measures the pressure of urine flow in the bladder along with urethral and voiding pressures. |
30 | $360 | $740 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
30 | $29 | $440 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
30 | $182 | $400 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
27 | $103 | $294 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
18 | $293 | $546 |
| Ultrasound of scrotum An imaging test that uses sound waves to create pictures of the scrotum and its contents. It helps evaluate the testicles and surrounding structures. |
16 | $83 | $150 |
| Ultrasound of abdomen and pelvis blood flow An ultrasound exam that uses sound waves to visualize and assess blood flow through the arteries and veins in the abdomen and pelvis. |
16 | $129 | $300 |
| Bladder emptying assessment A timed evaluation to measure how effectively the bladder empties urine. |
13 | $11 | $30 |
| Injection of biodegradable material next to prostate A procedure involving the injection of a biodegradable substance into the tissue surrounding the prostate gland. |
13 | $2,775 | $6,000 |
| Prostate radiation therapy device placement A device is placed in the prostate to facilitate radiation therapy. This procedure involves positioning the device to aid in the delivery of radiation treatment. |
13 | $68 | $300 |
| Endoscopic removal of bladder or urethra growth, 2.0-5.0 cm This procedure uses an endoscope to destroy or remove a growth from the bladder or urethra that measures between 2.0 and 5.0 centimeters. |
11 | $242 | $630 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.4% high complexity
19.2% medium
80.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,767
Total received (2018-2024)
Avg $967/year across 7 years
Top 27% in CA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
63
Companies
316
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,421 (94.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$347 (5.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$890
2023
$1,229
2022
$1,020
2021
$1,529
2020
$641
2019
$489
2018
$969
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Tolmar, Inc.
$174
ABBVIE INC.
$158
Sumitomo Pharma America, Inc.
$148
Antares Pharma, Inc.
$51
Astellas Pharma US Inc
$47
Janssen Biotech, Inc.
$45
Boston Scientific Corporation
$39
Ferring Pharmaceuticals Inc.
$36
Hollister Incorporated
$30
ABC Home Medical Supply, Inc.
$30
Blue Earth Diagnostics Limited
$25
Endo Pharmaceuticals Inc.
$25
Merck Sharp & Dohme LLC
$24
IMMUNITYBIO, INC.
$22
Myriad Genetic Laboratories, Inc.
$20
BIOTISSUE HOLDINGS INC.
$17
Top 3 companies account for 53.9% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$922
ABBVIE INC.
$491
AbbVie, Inc.
$385
AbbVie Inc.
$363
Janssen Biotech, Inc.
$360
Tolmar, Inc.
$244
Sumitomo Pharma America, Inc.
$227
Myovant Sciences Inc.
$222
Antares Pharma, Inc.
$214
Axonics, Inc.
$192
PFIZER INC.
$189
Aytu BioScience, Inc
$182
Cook Medical LLC
$159
Olympus America Inc.
$158
Endo Pharmaceuticals Inc.
$144
Bayer HealthCare Pharmaceuticals Inc.
$140
Acerus Pharmaceuticals Corporation
$139
Blue Earth Diagnostics Limited
$123
Teleflex LLC
$110
C. R. Bard, Inc. & Subsidiaries
$108
Laborie Medical Technologies Corp.
$103
EDAP TECHNOMED INC
$100
Boston Scientific Corporation
$94
Hollister Incorporated
$92
Mission Pharmacal Company
$89
Myriad Genetic Laboratories, Inc.
$88
Medtronic, Inc.
$85
Dendreon Pharmaceuticals LLC
$68
ABC Home Medical Supply, Inc.
$62
Kowa Pharmaceuticals America, Inc.
$54
Amgen Inc.
$54
Coloplast Corp
$53
Telix Pharmaceuticals
$47
UroGen Pharma, Inc.
$41
COLOPLAST CORP
$38
ACCORD HEALTHCARE, INC.
$37
Ferring Pharmaceuticals Inc.
$36
TISSUETECH, INC.
$30
180 Medical, Inc.
$29
MEDIVATION FIELD SOLUTIONS LLC
$28
Verity Pharmaceuticals Inc.
$27
Novartis Pharmaceuticals Corporation
$26
Photocure Inc
$25
BioTissue Holdings, Inc.
$24
UROGEN PHARMA, INC.
$24
Merck Sharp & Dohme LLC
$24
TOLMAR Pharmaceuticals, Inc.
$23
IMMUNITYBIO, INC.
$22
Accord Healthcare, Inc.
$22
Alnylam Pharmaceuticals Inc.
$22
AstraZeneca Pharmaceuticals LP
$21
NeoTract Inc.
$20
Analogic Corporation
$19
Ambu Inc.
$19
Allergan, Inc.
$19
Merck Sharp & Dohme Corporation
$19
Supernus Pharmaceuticals, Inc.
$19
E.R. Squibb & Sons, L.L.C.
$18
UROVANT SCIENCES INC
$18
BIOTISSUE HOLDINGS INC.
$17
Rochester Medical Corporation
$15
Sagent Pharmaceuticals
$14
C. R. BARD, INC. & SUBSIDIARIES
$12
Top 3 companies account for 26.6% of all-time payments
Associated products mentioned in payments ›
ADSTILADRIN · ADVANCE · ALLODERM · ANKTIVA · AVEED · Androgel · Axonics · Axonics r-SNM System · Axumin · BOTOX · CAMCEVI · CONTINENCE CARE · CYSTO-NEPHRO VIDEOSCOPE · Cook Medical Stents · Cysview · EDEX · ELIGARD · ERLEADA · GEMTESA · Genesis · Glydo · ILLUCCIX · INTERSTIM · JATENZO · JELMYTO · KEYTRUDA · LUPRON DEPOT · LYNPARZA · Lupron · Lupron Depot · MYRBETRIQ · Myrbetriq · NEOX · NOCDURNA · Natesto · Nubeqa · OPDIVO · ORGOVYX · OSTEOCOOL RF ABLATION · OTREXUP · OXLUMO · POSLUMA · PROLARIS · PROVENGE · Prolaris · RESONANCE · REZUM · Rezum Generator · SEGLENTIS · SPEEDICATH · SUTENT · SpeediCath · TLANDO · TOVIAZ · ThunderBeat · Trelstar · UROLIFT · Uribel · UroLift · UroLift System · Urocit-K · VaPro · VaPro Plus Pocket · XGEVA · XIAFLEX · XTANDI · XYOSTED · Xtandi · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (95%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
151
Per 100K population
4.8
County median income
$113,702
Nearest hospital
PROVIDENCE MISSION HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Pasin is a clinical cardiology specialist, with above-average Medicare volume (top 11% in CA), with low-engagement industry engagement, with 17 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Pasin experienced with bcg treatment for bladder cancer?
Based on Medicare claims data, Dr. Pasin performed 3,367 bcg treatment for bladder cancer services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Pasin receive payments from pharmaceutical companies?
Yes. Dr. Pasin received a total of $6,767 from 63 companies across 316 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Pasin's costs compare to other urology physicians in Mission Viejo?
Dr. Pasin's average Medicare payment per service is $45. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Pasin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Mission Viejo
Browse urology physicians in Mission Viejo ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in CA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in CA
Which CA urology physicians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
AbbVie, Inc. Payments to Doctors
See all physicians who received payments from AbbVie, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology